Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00399555 · ClinicalTrials.gov registry record

Neurodevelopmental Outcomes in Hypoplastic Left Heart Syndrome

A clinical trial of Congenital Heart Disease, sponsored by Emory University.

Completed
Registry status
28
Enrollment target
1
Study location

NCT00399555: Completed study of Congenital Heart Disease, sponsored by Emory University.

NCT00399555 is a study of Congenital Heart Disease that has completed, run by Emory University. The registered enrollment target is 28 participants, below the 474-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00399555, a study of Congenital Heart Disease, has completed, sponsored by Emory University.

COMPLETED
Registry status
28 participants
Enrollment target
1
Study location

Study Summary

There have been many improvements in the care of children with hypoplastic left heart syndrome (HLHS). This has helped these children survive longer. Because these children now live longer, researchers are recognizing developmental disabilities (the children are behind in their thinking or physical activity) in children with hypoplastic left heart syndrome. The purpose of this research study is to help the investigators learn more about developmental disabilities in children with hypoplastic left heart syndrome. During the time of your child's first surgery for hypoplastic left heart syndrome, a monitor was placed on your child's forehead to measure the oxygen levels in the brain. This monitor is called Near Infrared Spectrometry (NIRS). The researchers involved in this study want to know if oxygen levels in the blood vessels of the brain have any effect on developmental disabilities later in life in children with hypoplastic left heart syndrome. The researchers plan to enroll 60 research subjects.

Conditions Studied

Congenital Heart Disease

Study Locations (1)

Georgia

  • Children's Healthcare of Atlanta - Atlanta

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2006-11
Est. Completion 2009-07
Emory University

1,208 total trials

What the finished NCT00399555 record still lists

NCT00399555 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 474-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Congenital Heart Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00399555 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT00399555 about?

NCT00399555 is a clinical study titled "Neurodevelopmental Outcomes in Hypoplastic Left Heart Syndrome". There have been many improvements in the care of children with hypoplastic left heart syndrome (HLHS). This has helped these children survive longer. Because these children now live longer, researchers are recognizing developmental disabilities (the children are behind in their thinking or physical ...

What is the current status of trial NCT00399555?

This trial is currently completed. The enrollment target is 28 participants. The study started on 2006-11. Estimated completion is 2009-07.

What conditions does trial NCT00399555 study?

This clinical trial studies the following conditions: Congenital Heart Disease.

Who is sponsoring clinical trial NCT00399555?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00399555 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Congenital Heart Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00399555's enrollment target sits among peer trials

28 58th of 63 higher than 6 of 63 other Congenital Heart Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Congenital Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00399555, the US trial registry maintained by the National Library of Medicine. NCT00399555 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.